Stem cells and cancer

Por Bagley, Rebecca G., Teicher, Beverly A.
Publicado em 2009

Characteristics of human Ewing/PNET sarcoma models

Por Teicher, Beverly A., Bagley, Rebecca G., Rouleau, Cecile, Kruger, Ariel, Ren, Yi, Kurtzberg, Leslie
Publicado em 2011

JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice

Por Debeurme, Franck, Lacout, Catherine, Moratal, Claudine, Bagley, Rebecca G, Vainchenker, William, Adrian, Francisco, Villeval, Jean-Luc
Publicado no J Cell Mol Med (2015)

Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia

Por NGUYEN, TRI-HUNG, WEBER, WILLIAM, HAVARI, EVIS, CONNORS, TIMOTHY, BAGLEY, REBECCA G., McLAREN, RAJASHREE, NAMBIAR, PRASHANT R., MADDEN, STEPHEN L., TEICHER, BEVERLY A., ROBERTS, BRUCE, KAPLAN, JOHANNE, SHANKARA, SRINIVAS
Publicado em 2012

Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer

Por Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca G., Wang, Yamei, Conlan, Maureen G., Kabos, Peter
Publicado no J Clin Oncol (2021)

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions...

Por Jager, Agnes, de Vries, Elisabeth G. E., der Houven van Oordt, C. Willemien Menke-van, Neven, Patrick, Venema, Clasina M., Glaudemans, Andor W. J. M., Wang, Yamei, Bagley, Rebecca G., Conlan, Maureen G., Aftimos, Philippe
Publicado no Breast Cancer Res (2020)